ThermoDox: Clinical Trials

3 trials of ThermoDox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Unknown 1, Withdrawn 1

Follow ThermoDox: new trials by email Literature Review of ThermoDox trials Research Report on ThermoDox

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PanDox: Targeted Doxorubicin in Pancreatic Tumours
Focused Ultrasound, Doxorubicin, ThermoDox - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
Phase 1WithdrawnUniversity of Oxford2021-06-162023-04-12
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer
LTLD, MR-HIFU induced hyperthermia, Cyclophosphamide - Metastatic Breast Cancer, Breast Cancer
Phase 1UnknownUMC Utrecht122021-03-012021-02-17
A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
ThermoDox - Hepatocellular Carcinoma, Liver Neoplasms
Phase 1CompletedImunon302007-02-012019-02-07

Conditions studied

Hyperthermia (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Ductal, Breast (1)  ·  Carcinoma, Hepatocellular (1)  ·  Liver Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Imunon (1)  ·  UMC Utrecht (1)  ·  University of Oxford (1)

Countries

Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Britt BM Suelmann, MD (1)  ·  Mark Middleton (1)

Results publications

PMID 33243800, PMID 37741968

NIH funding

2015 (1)